ArticleFrontiers in pharmacology2022

Inflammation-Independent Antinociceptive Effects of DF2755A, a CXCR1/2 Selective Inhibitor: A New Potential Therapeutic Treatment for Peripheral Neuropathy Associated to Non-Ulcerative Interstitial Cystitis/Bladder Pain Syndrome.

Laura Brandolini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.